Baoxin Asia-Pacific (Shenzhen)

Baoxin Asia-Pacific (Shenzhen) is located on the second floor of International Biopharmaceutical Base. It is a high-tech company with investment by American CryoStem and Hong Kong Health Innovative Technology and engaged inresearch and development, manufacturing and marketing of cosmetic and anti-agingbiological technologies in Shenzhen. The company has reached an agreement with China National Pharmaceutical Group Company to jointly build the world’s first full-chain stem cell production line based on biological sample bank and biological information data platform. It will be the world’s first research and marketing enterprise engaged in the vertical market that will link aesthetics, cosmetics and anti-aging sectors through the Internet.

Baoxin is headed by the world’s top experts, including Gao Dayong, chairman of International Society for Low Temperature Biology and Medicine and adjunct professor of the Department of Bioengineering at the University of Washington, Michael L. Moeller, American CryoStem's former chief scientific officer, Professor Lin Bingquan, director with CUHK Stem Cell Research Center, and Professor Ann Chidgey with Anatomy and Developmental Biology, Monash Biomedicine Discover Institute.  

Baoxin is devoted to becoming a driver for international industrial innovation, a human fat bank and a technological service center that meets the FDA standards, and a clinical research base for stem cells and regeneration medicine center. It has set up a workstation in cooperation with the Chinese Academy of Engineering and established an incubation platform for global biopharmaceutical industry in Futian District.